
CTNM Technical Analysis Summary (NASDAQ)
Analyze CTNM on the NASDAQ with RSI, MACD, ADX, Bollinger Bands, support, resistance, momentum, and the latest technical trading signals.
Disclaimer for Technical Analysis Page
The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full DisclaimerCTNM Technical Analysis Summary (NASDAQ)
Contineum Therapeutics, Inc. (NASDAQ: CTNM) stock currently shows a neutral trend on the NASDAQ, supported by momentum and balanced buying pressure.
Technical conditions suggest Contineum Therapeutics, Inc. on the NASDAQ is awaiting a decisive move. This mix signals that Contineum Therapeutics, Inc. is trading in a balanced range with no clear breakout yet.
RSI (14): 49.16
Stochastic %K: 29.20
Williams %R: -76.15
Rate of Change (ROC): -3.81
Takeaway:Contineum Therapeutics, Inc. shows weakening momentum, with sellers gaining the edge.
MACD: 0.15
ADX: 19.47
ATR (14): 0.98
CCI (14): -38.27
Takeaway:Contineum Therapeutics, Inc. shows a neutral trend, with weak conviction and limited volatility.
Takeaway:Contineum Therapeutics, Inc. trades closer to support, showing weaker momentum within bands.
Takeaway:Contineum Therapeutics, Inc. trades below the trend line, showing weaker momentum inside the channel.
Overall Takeaway:CTNM shows bearish money flow, with sellers dominating volume and vigor.
Bullish Signals
MACD above 0 → bullish trend confirmation.
MFI below 80 → room for more buying without overbought risk.
Bearish Signals
MACD below signal line → short-term caution on momentum.
RVI below 50 → vigor tilted toward sellers.
Overall Recommendation:Technical indicators for Contineum Therapeutics, Inc. are mixed, suggesting a Hold or wait-and-see approach.